Ginkgo Bioworks to discover and develop novel vaccine adjuvants
Drug Discovery World
FEBRUARY 20, 2024
The contract was awarded by the Defense Threat Reduction Agency’s (DTRA) Joint Science and Technology Office (JSTO) for the Chemical and Biological Defense (CBD) Program, through the Medical Chemical, Biological, Radiological, and Nuclear (CBRN) Defense Consortium (MCDC) requirement 22-05, ‘Adjuvant Activity to Vaccines Prototype’.
Let's personalize your content